January 9, 2025 - 19:58

Attorneys Heidi Urness and Rudy Cerone have shared insights into the opportunities available within the realm of distressed marijuana businesses. As the cannabis industry continues to evolve, many companies face significant challenges, creating a landscape ripe for investment and strategic partnerships.
Urness emphasizes the importance of due diligence when evaluating these businesses. She notes that understanding the underlying reasons for distress—be it financial mismanagement, regulatory hurdles, or market competition—is crucial in determining whether a business can be turned around.
Cerone adds that potential investors should look for signs of resilience and adaptability within a company. Factors such as a strong brand presence, a loyal customer base, and innovative product offerings can indicate a business's potential for recovery.
In a market that remains volatile, Urness and Cerone advocate for a cautious yet optimistic approach, encouraging stakeholders to recognize the unique opportunities that distressed marijuana businesses can offer.
April 27, 2026 - 03:51
Business owners ask St. Pete to increase funding for roadway improvementsNavigating a dangerous dash across five lanes of traffic has become a daily reality for pedestrians and customers along Dr. Martin Luther King Jr. Street South in St. Petersburg, according to local...
April 26, 2026 - 03:01
World IP Day 2026: "Ready, Set, Innovate" – Celebrating Small Business and Entrepreneurial SpiritSmall businesses, innovators, and creators are the driving forces behind economic growth and technological advancement, and their contributions are being celebrated this World Intellectual Property...
April 25, 2026 - 18:27
A Shifting Landscape: How Beloved Family Businesses on the North Fork Are Navigating ChangeThis week’s editorial examines the profound ripple effects of transitions sweeping through cherished family-run enterprises that have anchored the North Fork community for generations. For...
April 25, 2026 - 03:05
Tirzepatide Shows Promise for Heart Patients Undergoing TAVR and PCI ProceduresTwo new studies have revealed that the popular weight loss drug tirzepatide may offer significant benefits for patients undergoing transcatheter aortic valve replacement (TAVR) and percutaneous...